Menu
Back to Journals » International Journal of Nanomedicine » Volume 17
Antiviral Activity of Chitosan Nanoparticles Encapsulating Curcumin Against Hepatitis C Virus Genotype 4a in Human Hepatoma Cell Lines [Retraction]
Authors Loutfy SA , Elberry MH , Farroh KY, Mohamed HT , Mohamed AA, Mohamed EB, Faraag AHI , Mousa SA
Received 30 June 2022
Accepted for publication 30 June 2022
Published 5 July 2022 Volume 2022:17 Pages 2891—2892
Loutfy SA, Elberry MH, Farroh KY, et al. Int J Nanomedicine. 2020;15:2699–2715.
The Editor and Publisher of International Journal of Nanomedicine wish to retract the published article. Concerns were raised regarding the alleged duplication of images in Figure 8. The authors responded to our queries and explained the western blot experiments were performed by a commercial laboratory; however, they were unable to provide all the original data. The data that was provided showed inconstancies between what was considered original western blot data and what was shown in Figure 8. This raised concerns over the reliability and validity of the findings and the Editor requested for the article to be retracted and the authors do not agree with this decision.
Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction.
The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.
© 2022 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.